Frequency of androgenic cutaneous adverse events associated with levonorgestrel intrauterine devices: An analysis of the Food and Drug Administration Adverse Event Reporting System database

J Am Acad Dermatol. 2024 Nov 3:S0190-9622(24)03061-5. doi: 10.1016/j.jaad.2024.10.045. Online ahead of print.

Authors

Lydia Cassard¹, Jameson Mitchell², Melissa Piliang³

Affiliations

¹ Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio. Electronic address: cassarl@ccf.org.
² Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.
³ Department of Dermatology, Cleveland Clinic, Cleveland, Ohio; Department of Pathology, Cleveland Clinic, Cleveland, Ohio.

PMID: 39500394
DOI: 10.1016/j.jaad.2024.10.045

No abstract available

Keywords: acne; alopecia; androgen; hirsutism; hormonal contraceptives; intrauterine device; levonorgestrel; progestin.